Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to $3.2 million.

  • Ovid Therapeutics' Prepaid Assets rose 340.29% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 340.29%. This contributed to the annual value of $2.9 million for FY2024, which is 2386.39% down from last year.
  • As of Q3 2025, Ovid Therapeutics' Prepaid Assets stood at $3.2 million, which was up 340.29% from $3.7 million recorded in Q2 2025.
  • Ovid Therapeutics' 5-year Prepaid Assets high stood at $5.7 million for Q2 2023, and its period low was $1.8 million during Q1 2023.
  • Over the past 5 years, Ovid Therapeutics' median Prepaid Assets value was $2.9 million (recorded in 2025), while the average stood at $3.2 million.
  • In the last 5 years, Ovid Therapeutics' Prepaid Assets surged by 10822.05% in 2023 and then crashed by 3289.05% in 2024.
  • Ovid Therapeutics' Prepaid Assets (Quarter) stood at $2.7 million in 2021, then decreased by 11.27% to $2.4 million in 2022, then surged by 58.16% to $3.8 million in 2023, then decreased by 23.86% to $2.9 million in 2024, then grew by 12.43% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $3.7 million for Q2 2025, and $2.9 million during Q1 2025.